Introduction
According to Acumen Research and Consulting, the global FISH Probe market is expected to grow at noteworthy CAGR around 6.5 % throughout the forecast period and reach around US$ 1 billion by 2026.
Fluorescent in situ hybridization (FISH) is a method used by molecular cytogenetic devices to visualize and map the genetic components of an individual. The method is used to distinguish fluorescent samples attached to the chromosome with a fluorescent microscope. FISH method has broad applications in the diagnostic sector such as structural and numerical chromosome defects, marker chromosome characterisation, drug tracking and identification of unusual and genetic conditions. The method also applies in clinical studies, including gene mapping and somatic cell hybrid characterization. Three separate FISH samples, each with distinct apps, are commercially accessible.
The report provides analysis of global FISH Probe market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
Market Dynamics
Increasing demand is anticipated to drive demand in future years for IVD diagnostic tools for different chronic diseases. The elevated degree of reliability, speed and awareness of the technology of the FISH probe which is to propagate the FISH market is ascribed to the increasing demand for IVD. In medical diagnostics, DNA sample-based diagnosis is gaining in popularity to determine suspected illnesses induced by pathogen or bacteria. Moreover, identifying the new diagnostic market regions, increasing diagnostic test automation and investments in pharmaceutical research and pharmaceutical research are the main drivers of development. Increased incidence of genetic disorders like Acute Lymphoblastic Leukemia (ALL) drives market development further. In 2018, nearly 7,000 fresh instances of ALL, with over 1500 fatalities, were diagnosed in Instance, according to the American Cancer Society.
The increased incidence of cytogenic-based illnesses, such as genetic abnormalities and cancer, in conjunction with demand for fast, sensitive and precise disease validation prediction methods is expected to increase FISH testing methods and thus increase the development of markets over the projected period.
The growth in the Fluorescent In Situ Hybridisation (FISH) test industry is also attributable to the growing R&D projects undertaken by different main players in the creation of new biomarkers and pipeline products for disease specific waiting for regulatory authorization. The market will be further driven by increased awareness, increased healthcare costs and the creation of new samples.
Type Outlook
Due to increasing demand for molecular profiling by healthcare practitioners, mRNA segment retained the biggest income market share in 2018. The increasing demand is further supported by technologically sophisticated molecular pathological instruments which assist in disease prognosis and stratification for adequate therapy.
Most of the RNA samples are used to analyze the cancer and help differentiate between subtypes of cancer. Companies such as the Advanced Cell Diagnostics series on Cancer and Infectious Diseases RNAscope and the Stellaris RNA BioSearch Technologies are developing new samples aiming at disease-specific RNA. Include INFORM HER 2/NEU sample from Ventana Medical Systems, PATHYVISION HER-2 from Abbott Molecular and HER2 FISH PharmDx from Dako Danmark, which have been recently approved as fluorescent hybridization kits for accompanying diagnostic use.
Market players provide custom-made, precise test development services in accordance with customer requirements. The expensive nature of the reagent, hard RNA tagging procedures and more complex procedures are expensive due to the synthesis of the RNA probes. RNA samples are more preferable since RNA-RNA hybrids are known to be stably more than DNA-RNA hybrids that increase the efficiency of the labeling response. Roche Molecular's Ventana ALK CDx testing by Ventana Medical systems and RG7422 PI3 K Inh waiting for permission and anticipated to be marketed during the projected timeframe.
Application Outlook
The hybridizing fluorescent-in-situ probe is most often used in genetic and cancer studies. Increasing cancer incidence worldwide and demand for delicate, quick and precise molecular diagnostic exams will drive general market development in the coming years. FISH samples are commonly used to detect breast and lung cancer in cancer diagnostics.
Genetic diseases segments are anticipated to enjoy quicker demand than cancer and other segments, depending on the present rate of execution and future opportunities of development. In the present situation, for example, FISH samples ' market penetration is highest in cancer diagnostics and consequently the segment has accounted for a greater market share.
On the other side, for other medical apps, the penetration of these samples is relatively less, accounting therefore for a relatively lower market share. Increased R&D in genetic and other infectious disease screening is, however, projected to be a profitable platform in the near future. With genetic diseases, the market penetration is currently lower, but the R&D activity in chromosomal aberrations is anticipated to increase at a substantial pace.
End Use Stance
The most significant method to detect genetic abnormalities is fluorescence in situ hybridisation. They are frequently used in clinical, complementary and research studies. Due to the broad applications in the identification of genetic disorders, cancer and infectious illnesses, clinical segments were the biggest markets share in 2018.
The specificity and elevated sensitivity of this technology and the fast performance tests have turned it into an important cytogenetic test that provides significant results for hematological malignancies and solid tumors research and diagnostic studies.
These samples are used in gene mapping and genetic aberrations study studies and the identification of new oncogenes in the detection and therapy of cancer. It is also used for gene mapping and identification in molecular screening of novel oncogenes. Extensive genetic abbreviation studies are being ascribed to the growth segment, with illnesses and the increased incidence of genomic abnormalities and cancer.
Regional Stance
High incidence of genetic disorders resulting in birth defects, developmental disabilities and other metabolisms are among those attributed to development. North America has been ascribed the highest share of revenues in 2018. In 2017, around 3% to 4% of newborns in the United States were born with genetic defects, the Center for Disease Control and Prevention (CDC). Roughly 10% of adults and 30% of kids were hospitalized in the nation due to genetic illnesses. Fluorescent ISH is estimated to be 98% accurate to detect chromosomal aberrations that cause these disturbances.
The use of this test is also increasing in this region and will drive demand for multiple illnesses, such as cancer and genetic disorders. The market development is mainly ascribed to increased knowledge among individuals of genetic disease early diagnosis, increased availability incomes and extremely well-established R&D facilities. Favorable healthcare reimbursement policies and government reforms are anticipated to push the industry further.
In the coming years, Asia Pacific is expected to show profitable development. In this area, the sector is increasing in terms of the generation of income from cytogenetics and molecular diagnostics. The variables that encourage regional development are the presence of government supporting measures for growing producers ' and public investments in biotechnology and elevated untapped possibilities.
Continuous R&D for cancer therapy also makes demand for cancer studies easier and should in the near future fuel regional demand. The growing use of fresh molecular cytogenetic methods, increasing outsourcing operations and demand for early diagnosis and disease detection are expected to boost regional development. regional growth is expected.
Market Segmentation
Global FISH Probe Market, By Technology
- Q FISH
- Flow FISH
- Other FISH
Global FISH Probe Market, By Type
Global FISH Probe Market, By Application
- Genetic Diseases
- Cancer Research
- Breast
- Lung
- Gastric
- Prostrate
- Bladder
- Hematological
- Cervical
- Other
- Other
Global FISH Probe Market, By End Use
- Clinical
- Research
- Companion diagnostics
Global FISH Probe Market, By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
The market research study on “FISH (Fluorescent in Situ Hybridization) Probe Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global FISH Probe market segments with market dynamics and their impact. The report also covers basic technology development policies.
Key Players & Strategies
Life Science Technologies; Oxford Gene Technologies; Genemed Biotechnologies, Abnova Corporation; Inc. PerkinElmer Inc.; Biosearch Technologies Inc.; and F. Hoffmann-La Roche AG are main players running on the market. Some businesses including Abbott Laboratories and Agilent Technologies have large market shares because of the comprehensive product portfolio such as Vysis EGR1 FISH Probe Kit by Abbott are competitive by nature on the market.
Companies use competitive approaches to gain benefit, such as fresh product development, strategic partnerships and regional expansions. Oxford Gene Technology, for example, has extended its Cytocell Aquarius FISH range of pathology samples in 2016. In 2016, the firm also launched a fresh line of in situ hybridizing non-human fluorescent samples for pig, mouse and chicken.
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of FISH (Fluorescent in Situ Hybridization) Probe
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. FISH (Fluorescent in Situ Hybridization) Probe Market By Technology
1.2.2.1. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share By Technology in 2017
1.2.2.3. Q FISH
1.2.2.4. Flow FISH
1.2.2.5. Other FISH
1.2.3. FISH (Fluorescent in Situ Hybridization) Probe Market By Type
1.2.3.1. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.3.2. RNA
1.2.3.3. mRNA
1.2.3.3.1. miRNA
1.2.3.3.2. Other
1.2.3.3.3. DNA
1.2.4. FISH (Fluorescent in Situ Hybridization) Probe Market By Application
1.2.4.1. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Genetic Diseases
1.2.4.3. Cancer Research
1.2.4.3.1. Breast
1.2.4.3.2. Lung
1.2.4.3.3. Gastric
1.2.4.3.4. Prostrate
1.2.4.3.5. Bladder
1.2.4.3.6. Hematological
1.2.4.3.7. Cervical
1.2.4.3.8. Other
1.2.4.4. Other
1.2.5. FISH (Fluorescent in Situ Hybridization) Probe Market By End Use
1.2.5.1. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.5.2. Clinical
1.2.5.3. Research
1.2.5.4. Companion diagnostics
1.2.6. FISH (Fluorescent in Situ Hybridization) Probe Market by Geography
1.2.6.1. Global FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global FISH (Fluorescent in Situ Hybridization) Probe Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global FISH (Fluorescent in Situ Hybridization) Probe Major Manufacturers in 2017
3.3. R&D Status and Technology Technology of Global FISH (Fluorescent in Situ Hybridization) Probe Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global FISH (Fluorescent in Situ Hybridization) Probe Major Manufacturers in 2017
CHAPTER 4. FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY TECHNOLOGY
4.1. Global FISH (Fluorescent in Situ Hybridization) Probe Revenue By Technology
4.2. Q FISH
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Flow FISH
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other FISH
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY TYPE
5.1. Global FISH (Fluorescent in Situ Hybridization) Probe Revenue By Type
5.2. RNA
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. mRNA
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. miRNA
5.3.4. Other
5.3.5. DNA
CHAPTER 6. FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY APPLICATION
6.1. Global FISH (Fluorescent in Situ Hybridization) Probe Revenue By Application
6.2. Genetic Diseases
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cancer Research
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3.3. Breast
6.3.4. Lung
6.3.5. Gastric
6.3.6. Prostrate
6.3.7. Bladder
6.3.8. Hematological
6.3.9. Cervical
6.3.10. Other
6.4. Other
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY END USE
7.1. Global FISH (Fluorescent in Situ Hybridization) Probe Revenue By End Use
7.2. Clinical
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Research
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Companion diagnostics
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
8.1. North America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
9.1. Europe FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
10.1. Asia-Pacific FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
11.1. Latin America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
12.1. Middle East FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 13. AFRICA FISH (FLUORESCENT IN SITU HYBRIDIZATION) PROBE MARKET BY COUNTRY
13.1. Africa FISH (Fluorescent in Situ Hybridization) Probe Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa FISH (Fluorescent in Situ Hybridization) Probe Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
13.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
13.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
13.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 14. COMPANY PROFILE
14.1. Life Science Technologies
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Technology Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Oxford Gene Technologies
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Technology Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Genemed Biotechnologies
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Technology Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Abnova Corporation; Inc
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Technology Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. PerkinElmer Inc.
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Technology Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Biosearch Technologies Inc.
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Technology Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Others
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Technology Portfolio
14.7.5. Key Developments
14.7.6. Strategies
CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope
![FISH (Fluorescent in Situ Hybridization) Probe Market (By Technology: Q FISH, Flow FISH, Other FISH; By Type: RNA [mRNA, miRNA, Other], DNA; By Application: Genetic Diseases, Cancer Research [Breast, Lung, Gastric, Prostrate, Bladder, Hematological, Cervical, Other], Other; By End Use: Clinical, Research, Companion diagnostics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026](assets/images/format-png.png "FISH (Fluorescent in Situ Hybridization) Probe Market (By Technology: Q FISH, Flow FISH, Other FISH; By Type: RNA [mRNA, miRNA, Other], DNA; By Application: Genetic Diseases, Cancer Research [Breast, Lung, Gastric, Prostrate, Bladder, Hematological, Cervical, Other], Other; By End Use: Clinical, Research, Companion diagnostics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026")
